Objective:

To announce the FDA approval of the Dual Energy THERMOCOOL SMARTTOUCH SF Platform for catheter ablation.

Approach:

• Platform Overview: The platform allows delivery of both pulsed field and radiofrequency energy through a single catheter.
• Integration: It is integrated with the CARTO ecosystem, which includes mapping, imaging, and pulsed field index guidance.

Key Findings:

• The platform is built on the THERMOCOOL SMARTTOUCH SF catheter platform, used in over one million US patients.
• It enables precise contact force delivery of energy tailored to patient anatomy and case complexity.
• First US procedures are expected to begin this summer as part of a phased rollout.

Interpretation:

The platform provides electrophysiologists with the flexibility to choose between RF and PF energy based on procedural needs.

Limitations:

• Dhanunjaya Lakkireddy, MD, FHRS, MBA, is a consultant for Johnson & Johnson and was not compensated for his contribution to the announcement.

Conclusion:

The Dual Energy THERMOCOOL SMARTTOUCH SF Platform aims to enhance procedural confidence and adaptability in complex cases.

Sources:

• Johnson & Johnson Press Release